Nebulised hypertonic saline for cystic fibrosis
P Wark, VM McDonald, S Smith - Cochrane Database of …, 2023 - cochranelibrary.com
Background Hypertonic saline enhances mucociliary clearance and may lessen the
destructive inflammatory process in the airways. This is an update of a previously published …
destructive inflammatory process in the airways. This is an update of a previously published …
Devices for improved delivery of nebulized pharmaceutical aerosols to the lungs
Nebulizers have a number of advantages for the delivery of inhaled pharmaceutical
aerosols, including the use of aqueous formulations and the ability to deliver process …
aerosols, including the use of aqueous formulations and the ability to deliver process …
Hypertonic saline suppresses NADPH oxidase-dependent neutrophil extracellular trap formation and promotes apoptosis
A Nadesalingam, JHK Chen, A Farahvash… - Frontiers in …, 2018 - frontiersin.org
Tonicity of saline (NaCl) is important in regulating cellular functions and homeostasis.
Hypertonic saline is administered to treat many inflammatory diseases, including cystic …
Hypertonic saline is administered to treat many inflammatory diseases, including cystic …
Timing of hypertonic saline inhalation for cystic fibrosis
M Elkins, R Dentice - Cochrane Database of Systematic …, 2020 - cochranelibrary.com
Background Inhalation of hypertonic saline improves sputum rheology, accelerates
mucociliary clearance and improves clinical outcomes of people with cystic fibrosis. This is …
mucociliary clearance and improves clinical outcomes of people with cystic fibrosis. This is …
In vitro determination of the main effects in the design of high-flow nasal therapy systems with respect to aerosol performance
G Bennett, M Joyce, L Sweeney, R MacLoughlin - Pulmonary therapy, 2018 - Springer
Introduction The use of concurrent aerosol delivery during high-flow nasal therapy (HFNT)
may be exploited to facilitate the delivery of a variety of prescribed medications for …
may be exploited to facilitate the delivery of a variety of prescribed medications for …
Development of a high-flow nasal cannula and pharmaceutical aerosol combination device
Background: Aerosol drug delivery to the lungs is known to be very inefficient during all
forms of noninvasive ventilation, especially when the aerosol is administered simultaneously …
forms of noninvasive ventilation, especially when the aerosol is administered simultaneously …
[HTML][HTML] Cystic fibrosis-related diabetes (CFRD) and cognitive function in adults with cystic fibrosis
Background Being able to function cognitively is imperative for successful achievement in
school, working life, and disease self-management. Diabetes is known to cause changes in …
school, working life, and disease self-management. Diabetes is known to cause changes in …
Hypertonic solution in severe COVID-19 patient: a potential adjuvant therapy
M Gennari-Felipe, L Borges, A Dermargos… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) features hyper-inflammation, cytokine storm,
neutrophil function changes, and sodium chloride (NaCl) homeostasis disruption, while the …
neutrophil function changes, and sodium chloride (NaCl) homeostasis disruption, while the …
Nocturnal high-flow nasal cannula therapy and sinonasal symptoms during cystic fibrosis exacerbations
MD Davis, J Brockbank, R Hayden… - Respiratory …, 2023 - rc.rcjournal.com
BACKGROUND: Both nasal obstruction and sleep disturbance are common in patients with
cystic fibrosis (CF). In patients with obstructive sleep apnea (OSA), studies suggest that …
cystic fibrosis (CF). In patients with obstructive sleep apnea (OSA), studies suggest that …
[PDF][PDF] 结肠癌中NMNAT2, p53 的表达及三者相关性研究
喻玉, 肖国辉, 王天刚, 赵龙, 杨伟兴 - 现代生物医学进展, 2019 - biomed.cnjournals.com
摘要目的: 检测结肠癌中烟酰胺核苷酸腺苷转移酶2 (Nicotinamide nucleotide adenosine
transferase 2, NMNAT2), p53 的表达并分析三者之间的关系. 方法: 免疫组化S-ABC 法(< 4 …
transferase 2, NMNAT2), p53 的表达并分析三者之间的关系. 方法: 免疫组化S-ABC 法(< 4 …